Current report 25/2021– Notice on convening the Ordinary General Meeting of Celon Pharma S.A. on June 29, 2021 with draft resolutions

Date prepared: 06/02/2021                                                                                                    

Abbreviated name of the issuer: CELON PHARMA S.A.

Subject: Notice on convening the Ordinary General Meeting of Celon Pharma S.A. on June 29, 2021 with draft resolutions

Legal basis Article 56 subs. 1 point 2 of the Act on Public Offering – current and periodical information

Content of the report:                                                                                                                   

Management Board of Celon Pharma S.A. (“the Company”), acting pursuant to Article 395 § 1, Article 399 § 1, Article 402 (1) and Article 402 (2) of the Commercial Companies Code, hereby convenes the Ordinary General Meeting on 29 June 2021 at 09:30 am, which will be held at the Company's Research And Development Center in Kazuń at ul. Marymoncka 15.

The planned agenda:

1. Opening of the Ordinary General Meeting.
2. Election of the Chairperson of the Ordinary General Meeting.
3. Confirmation that the Ordinary General Meeting has been convened correctly and has the capacity to adopt binding resolutions.
4. Adoption of the agenda of the Ordinary General Meeting.
5. Election of the Returning Committee of the Ordinary General Meeting.
6. Examination of the Management Board’s report on the Company’s business activities for the year 2020, the Company’s Financial Statements for the financial year 2020, the Management Board’s recommendation on the distribution of profit for the financial year 2020.
7. Examination of the Supervisory Board’s report for the financial year 2020 taking into account requirements specified in the Best Practice for GPW Listed Companies 2016.
8. Adoption of a resolution on approving the Management Board’s report on the Company’s business activities for the year 2020.
9. Adoption of a resolution on approving the Company’s Financial Statements for the financial year 2016;
10. Adoption of a resolution on the distribution of profit for the financial year 2020.
11. Adoption of a resolution on approving the Supervisory Board’s report for the financial year 2020 taking into account requirements specified in the Best Practice for GPW Listed Companies 2016.
12. Adoption of resolutions on acknowledging the fulfilment of duties by Members of the Management Board in 2020.
13. Adoption of resolutions on acknowledging the fulfilment of duties by Members of the Supervisory Board in 2020.
14. Adoption of a resolution on issuing an opinion on the „Report on remuneration of Members of the Management Board and the Supervisory Board of Celon Pharma S.A. for the years 2019 - 2020”
15. Any other business.
16. Closing of the General Meeting.

In this current report, the Company is attaching the full content of notice on convening the Ordinary General Meeting along with draft resolutions.

At the same time the Company informs that the Supervisory Board’s report referred to in points 7 and 11 of the agenda, as well as the report on remuneration of Members of the Management Board and the Supervisory Board referred to in point 14 of the agenda will be made available at a later date, immediately after they have been adopted by the Company’s Supervisory Board.